FDA Inspection 1135591 — TG Therapeutics, Inc.

TG Therapeutics, Inc. — FEI 3016405037

The FDA completed an inspection of TG Therapeutics, Inc. on January 29, 2021 in Morrisville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 29, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Morrisville, NC (United States)

Additional Details

Sponsor, Contract Research Organization